280 related articles for article (PubMed ID: 24571489)
1. Using viruses as nanomedicines.
van Kan-Davelaar HE; van Hest JC; Cornelissen JJ; Koay MS
Br J Pharmacol; 2014 Sep; 171(17):4001-9. PubMed ID: 24571489
[TBL] [Abstract][Full Text] [Related]
2. In vivo architectonic stability of fully de novo designed protein-only nanoparticles.
Céspedes MV; Unzueta U; Tatkiewicz W; Sánchez-Chardi A; Conchillo-Solé O; Álamo P; Xu Z; Casanova I; Corchero JL; Pesarrodona M; Cedano J; Daura X; Ratera I; Veciana J; Ferrer-Miralles N; Vazquez E; Villaverde A; Mangues R
ACS Nano; 2014 May; 8(5):4166-76. PubMed ID: 24708510
[TBL] [Abstract][Full Text] [Related]
3. Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision Medicine.
Sunderland KS; Yang M; Mao C
Angew Chem Int Ed Engl; 2017 Feb; 56(8):1964-1992. PubMed ID: 27491926
[TBL] [Abstract][Full Text] [Related]
4. Phage-based delivery systems: engineering, applications, and challenges in nanomedicines.
Wang H; Yang Y; Xu Y; Chen Y; Zhang W; Liu T; Chen G; Wang K
J Nanobiotechnology; 2024 Jun; 22(1):365. PubMed ID: 38918839
[TBL] [Abstract][Full Text] [Related]
5. Viral nanoparticles as platforms for next-generation therapeutics and imaging devices.
Steinmetz NF
Nanomedicine; 2010 Oct; 6(5):634-41. PubMed ID: 20433947
[TBL] [Abstract][Full Text] [Related]
6. Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers.
Raza F; Zafar H; You X; Khan A; Wu J; Ge L
J Mater Chem B; 2019 Dec; 7(48):7639-7655. PubMed ID: 31746934
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicine and Phage Capsids.
Serwer P; Wright ET
Viruses; 2018 Jun; 10(6):. PubMed ID: 29882754
[TBL] [Abstract][Full Text] [Related]
8. Designer adenoviruses for nanomedicine and nanodiagnostics.
Singh R; Kostarelos K
Trends Biotechnol; 2009 Apr; 27(4):220-9. PubMed ID: 19251331
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of nanomedicines for prostate cancer: An update.
Lakshmanan VK
Investig Clin Urol; 2016 Jan; 57(1):21-9. PubMed ID: 26966723
[TBL] [Abstract][Full Text] [Related]
10. Killing cancer cells by targeted drug-carrying phage nanomedicines.
Bar H; Yacoby I; Benhar I
BMC Biotechnol; 2008 Apr; 8():37. PubMed ID: 18387177
[TBL] [Abstract][Full Text] [Related]
11. Synthetic immunosurveillance systems: nanodevices to monitor physiological events.
Woappi YL; Jangiti R; Singh OV
Biosens Bioelectron; 2014 Nov; 61():152-64. PubMed ID: 24874659
[TBL] [Abstract][Full Text] [Related]
12. Multivalent viral capsids with internal cargo for fibrin imaging.
Obermeyer AC; Capehart SL; Jarman JB; Francis MB
PLoS One; 2014; 9(6):e100678. PubMed ID: 24960118
[TBL] [Abstract][Full Text] [Related]
13. Molecular imaging in nanomedicine - A developmental tool and a clinical necessity.
Dearling JLJ; Packard AB
J Control Release; 2017 Sep; 261():23-30. PubMed ID: 28624600
[TBL] [Abstract][Full Text] [Related]
14. Targeting Nanomedicines to Prostate Cancer: Evaluation of Specificity of Ligands to Two Different Receptors In Vivo.
Pearce AK; Fuchs AV; Fletcher NL; Thurecht KJ
Pharm Res; 2016 Oct; 33(10):2388-99. PubMed ID: 27225496
[TBL] [Abstract][Full Text] [Related]
15. Paradigm shift in bacteriophage-mediated delivery of anticancer drugs: from targeted 'magic bullets' to self-navigated 'magic missiles'.
Petrenko VA; Gillespie JW
Expert Opin Drug Deliv; 2017 Mar; 14(3):373-384. PubMed ID: 27466706
[TBL] [Abstract][Full Text] [Related]
16. Physical chemistry of nanomedicine: understanding the complex behaviors of nanoparticles in vivo.
Lane LA; Qian X; Smith AM; Nie S
Annu Rev Phys Chem; 2015 Apr; 66():521-47. PubMed ID: 25622189
[TBL] [Abstract][Full Text] [Related]
17. Chemically Modifying Viruses for Diverse Applications.
Mohan K; Weiss GA
ACS Chem Biol; 2016 May; 11(5):1167-79. PubMed ID: 26930417
[TBL] [Abstract][Full Text] [Related]
18. Plant virus nanoparticles: Novel and robust nanocarriers for drug delivery and imaging.
Alemzadeh E; Dehshahri A; Izadpanah K; Ahmadi F
Colloids Surf B Biointerfaces; 2018 Jul; 167():20-27. PubMed ID: 29625419
[TBL] [Abstract][Full Text] [Related]
19. Towards nanomedicines: design protocols to assemble, visualize and test carbon nanotube probes for multi-modality biomedical imaging.
Pascu SI; Arrowsmith RL; Bayly SR; Brayshaw S; Hu Z
Philos Trans A Math Phys Eng Sci; 2010 Aug; 368(1924):3683-712. PubMed ID: 20603377
[TBL] [Abstract][Full Text] [Related]
20. Peptide ligand-mediated targeted drug delivery of nanomedicines.
Jiang Z; Guan J; Qian J; Zhan C
Biomater Sci; 2019 Jan; 7(2):461-471. PubMed ID: 30656305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
